Fibrodysplasia Ossificans Progressiva
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Fibrodysplasia Ossificans Progressiva

What is the definition of Fibrodysplasia Ossificans Progressiva?

Fibrodysplasia ossificans progressiva is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone (ossified), forming bone outside the skeleton (extra-skeletal or heterotopic bone) that limits movement. This process generally becomes noticeable in early childhood, starting with the neck and shoulders and proceeding down the body and into the limbs.

What are the causes of Fibrodysplasia Ossificans Progressiva?

Variants (also known as mutations) in the ACVR1 gene cause fibrodysplasia ossificans progressiva. This gene provides instructions for making a member of a protein family called bone morphogenetic protein (BMP) type I receptors. The ACVR1 protein is found in many tissues of the body including skeletal muscle and cartilage. It helps to control the growth and development of the bones and muscles, including the gradual replacement of cartilage by bone (ossification) that occurs in normal skeletal maturation from birth to young adulthood.

How prevalent is Fibrodysplasia Ossificans Progressiva?

Fibrodysplasia ossificans progressiva is a very rare disorder, believed to occur in approximately 1 in 1 million people worldwide. Several hundred cases have been reported.

Is Fibrodysplasia Ossificans Progressiva an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Who are the top Fibrodysplasia Ossificans Progressiva Local Doctors?
Distinguished in Fibrodysplasia Ossificans Progressiva
Orthopedics
Distinguished in Fibrodysplasia Ossificans Progressiva
Orthopedics
Referral may be required

Ballad Health Medical Associates Associated Orthopedics

430 West Ravine Road, 
Kingsport, TN 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Todd Horton is an Orthopedics provider practicing medicine in Kingsport, Tennessee. Dr. Horton is rated as a Distinguished provider by MediFind in the treatment of Fibrodysplasia Ossificans Progressiva. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Progressive Osseous Heteroplasia, Fibrodysplasia Ossificans Progressiva, Osteoarthritis, and Carpal Tunnel Syndrome. Dr. Horton is board certified in American Board Of Orthopaedic Surgery. Dr. Horton is currently accepting new patients.

Elite in Fibrodysplasia Ossificans Progressiva
Elite in Fibrodysplasia Ossificans Progressiva
Referral may be required

Penn Orthopaedics University City - 8th Floor

3737 Market Street, 8th Floor, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients

Frederick Kaplan is an Orthopedics provider practicing medicine in Philadelphia, Pennsylvania. Dr. Kaplan is rated as an Elite provider by MediFind in the treatment of Fibrodysplasia Ossificans Progressiva. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Fibrodysplasia Ossificans Progressiva, Progressive Osseous Heteroplasia, Compartment Syndrome, Spinal Fusion, and Fasciotomy. Dr. Kaplan is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Fibrodysplasia Ossificans Progressiva
Elite in Fibrodysplasia Ossificans Progressiva
Referral may be required
London, ENG, GB 

Richard Keen practices practicing medicine in London, United Kingdom. Mr. Keen is rated as an Elite expert by MediFind in the treatment of Fibrodysplasia Ossificans Progressiva. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Fibrodysplasia Ossificans Progressiva, Hypophosphatemia, Rickets, and X-Linked Hypophosphatemia.

What are the latest Fibrodysplasia Ossificans Progressiva Clinical Trials?
An International Observational Registry Study to Further Describe Long-term Safety and Effectiveness of Palovarotene in Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Summary: The participants in this registry study will have fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare, severely disabling disease characterized by new bone formation in areas of the body where bone is not normally present (heterotopic ossification (HO)). HO is often preceded by painful, recurrent episodes of soft tissue swelling (flare-ups). This registry study will take place in cou...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

Summary: This Phase 2, Randomized, Double-Blind, Placebo-Controlled Study is intended to evaluate the Efficacy, Safety, and Tolerability and PK of INCB000928 administered to participants with a clinical diagnosis of fibrodysplasia ossificans progressiva (FOP).

Who are the sources who wrote this article ?

Published Date: July 15, 2022
Published By: National Institutes of Health